Methods.The study included two
interviews based on questionnaires regarding symptoms and side effects, the first held on the day the license was issued and the
second 6–8 weeks later. Cancer symptoms and cannabis side effects were documented on scales from 0 to 4 following the CTCAE.
The distress thermometer was used also. Results. Of the 211 patients who had a first interview, only 131 had the second interview,
25 of whom stopped treatment after less than a week. All cancer or anticancer treatment-related symptoms showed significant
improvement (